By using a similar gating strategy for studying LAMs in AML as reported by Yahya et al,15 we determined the percentage of LAMs defined as CD11b+Ly6G− in the BM and spleen of T‐ALL mice. This evidence concerns the gene LAMB2 and acute myeloid leukemia.